What is hemophilia?

Hemophilia is classified as a genetic disorder that results from an impairment in the body’s ability to form blood clots. This impairment is primarily due to deficiencies in specific clotting factors, which are proteins essential for normal coagulation. When an individual with hemophilia experiences a cut or injury, their blood does not clot effectively, leading to prolonged bleeding. This condition is usually inherited and most commonly affects males.

The focus on the genetic aspect distinguishes hemophilia from other conditions that may cause bleeding but do not necessarily involve the same underlying mechanisms of clotting factor deficiencies. Understanding the specific role of genetic mutations in hemophilia helps in its diagnosis, treatment, and management, including potential therapies such as factor replacement therapy.